Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
2.000
+0.070 (3.63%)
At close: Aug 19, 2026, 4:00 PM EDT
1.964
-0.036 (-1.82%)
After-hours: Aug 19, 2026, 6:51 PM EDT
Karyopharm Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $8 | Buy | Maintains | $8 | +300.00% | Aug 13, 2026 |
| Jefferies | Jefferies | Buy Maintains $14 → $11 | Buy | Maintains | $14 → $11 | +450.00% | Jul 31, 2026 |
| Robert W. Baird | Robert W. Baird | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Jul 31, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $16 → $7 | Buy | Maintains | $16 → $7 | +250.00% | Jul 31, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Downgrades $13 → $3 | Hold | Downgrades | $13 → $3 | +50.00% | Jul 31, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Hold Reiterates $5 → $7 | Hold | Reiterates | $5 → $7 | +250.00% | May 15, 2026 |
| Rodman & Renshaw | Rodman & Renshaw | Buy Initiates $28 | Buy | Initiates | $28 | +1,300.00% | Mar 9, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Mar 7, 2026 |